Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bronchial epithelial transcriptome reveals dysregulated interferon and inflammatory responses to rhinovirus in exacerbation-prone pediatric asthma
Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley
Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley
View: Text | PDF
Research Article Cell biology Immunology Pulmonology

Bronchial epithelial transcriptome reveals dysregulated interferon and inflammatory responses to rhinovirus in exacerbation-prone pediatric asthma

  • Text
  • PDF
Abstract

Host factors influencing susceptibility to rhinovirus-induced asthma exacerbations remain poorly characterized. Using organotypic bronchial epithelial cultures from well-characterized children with asthma and healthy children, this study investigated viral load kinetics and resultant host responses by bulk and single-cell transcriptomics and targeted protein analyses. Bronchial epithelium from exacerbation-prone children exhibited greater rhinovirus replication and a cascade of exaggerated downstream interferon (IFN), inflammatory, epithelial stress, and remodeling responses. These transcriptional patterns were confirmed and further refined using single-cell transcriptomics, revealing cell type–specific contributions — particularly from non-ciliated cell populations including secretory immune response, tuft, and basal cells. We observed that these post-infection differences were associated with lower pre-infection IFN-stimulated gene (ISG) expression and protein levels of the ISG CXCL10. Prophylactic IFN-β treatment reduced viral replication and normalized downstream responses, supporting low baseline (pre-infection) IFN tone as a modifiable causal determinant of host susceptibility to adverse rhinovirus-induced responses in exacerbation-prone children with asthma.

Authors

Naresh Doni Jayavelu, Basilin Benson, Patricia C. dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, Camile R. Gates, Andrew J. Nagel, Maria P. White, Nyssa B. Samanas, Kourtnie Whitfield, Teal S. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley

×

Figure 4

Single-cell RNA-Seq maps epithelial cell diversity and reveals cell type–specific activation of bulk-derived transcriptional modules following RV infection.

Options: View larger image (or click on image) Download as PowerPoint
Single-cell RNA-Seq maps epithelial cell diversity and reveals cell type...
(A) UMAP representation of the 316,712 cells recovered from samples collected from children with asthma (SE, 7 donors; NSE, 4 donors) and healthy controls (n = 3 donors). Mitotic basal: 8,281 cells; proliferative basal, 8,405 cells; basal, 53,663 cells; suprabasal, 20,403 cells; secretory, 52,727 cells; goblet, 63,542 cells; inflammatory, 14,361 cells; deuterosomal, 8,836 cells; mucociliated, 13,284 cells; ciliated, 67,654 cells; ionocytes, 2,407 cells; tuft/PNECs, 2,251 cells. (B) The dot plot shows the expression of marker genes distinguishing distinct cell populations from the EmptyDrops-based processing pipeline (53). The color intensity indicates the magnitude of marker gene expression, and the size of the circle denotes percentage of cells expressing the marker gene. (C) Bar plot showing the mean proportions of identified epithelial cell populations by single-cell RNA-Seq by condition (uninfected samples and samples 2 days post-infection) and donor groups (SE, 7 donors; NSE, 4 donors; HC, 3 donors). (D) Dot plot showing the cumulative link model (CLM) estimates for select modules in RV-infected samples across all 12 cell types. The corresponding bottom plots show the relative CLM estimates on a UMAP space.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts